Clinical Trial Update: Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer

View source ↗

Summary

A clinical trial update evaluating the feasibility of a novel neoantigen-reactive CD8+ T cell (NART) detection technology for postoperative minimal residual dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Minimal Residual Disease, Pancreatic Cancer Resectable | Status: NOT_YET_RECRUITING